| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2017 |
| Sales | 68,907 | 73,775 | 69,546 | 19,998 | 17,523 |
| Sales Growth | -6.60% | +6.08% | +247.76% | +14.12% | -35.19% |
| Net Income | -32,205 | -4,129 | 3,361 | -6,153 | 1,581 |
| Net Income Growth | -679.97% | -222.85% | +154.62% | -489.18% | -62.62% |
Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Nuvo Pharmaceuticals Inc doing business as Miravo Healthcare which is a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquires growth-oriented, complementary products for Canadian and international markets.
Fiscal Year End Date: 12/31